Roughly an hour earlier, the 25-year-old had walked out to the sort of wild reaction that greeted John McGinn hitting the back of the net against Haiti, with screams and hollers from the teenagers ...

Roche has received the US Food and Drug Administration (FDA) priority review for its supplemental biologics licence application (sBLA) for adjuvant Tecentriq (atezolizumab) and Tecentriq Hybreza ...

Marina is that curiosity, a cult female star making pop music. Unlike most female pop stars of her longevity, she’s never had one of those monster hits that everyone knows. She has no “Poker Face”, ...

A Prescription Drug User Fee Act target date of September 30, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug ...

Cogent Biosciences (COGT) is poised for two product launches later this year after the FDA granted priority review for its marketing application for its lead candidate, bezuclastini, for a rare form ...

In the FINE-ONE trial, finerenone met its primary endpoint by significantly reducing the urinary albumin-to-creatinine ratio by 25% compared with placebo over 6 months in adults with T1D and CKD. The ...

Bayer (BAYRY) (BAYZF) announced on Thursday that the U.S. Food and Drug Administration has granted priority review for its marketing application seeking a label expansion for its kidney disease ...

May 21 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Thursday that the U.S. Food ⁠and Drug Administration had accepted its supplemental New Drug Application for finerenone and granted priority ...

“Secondary stroke remains a serious and persistent challenge, and the FDA’s Priority Review designation underscores the urgency of advancing potential new approaches in secondary stroke prevention,” ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) and granted Priority Review designation for its investigational oral Factor ...